| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |